Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9939655 | 1.00 | ELANE (0.53) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| SCHEMBL133568 | 1.00 | ELANE (0.53) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| SCHEMBL28176721 | 0.98 | ELANE (0.51) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| SCHEMBL28281300 | 0.98 | ELANE (0.51) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| SCHEMBL28299146 | 0.98 | ELANE (0.51) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10445713 | 0.98 | ELANE (0.51) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL9613925 | 0.98 | ELANE (0.51) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL2037585 | 0.98 | ELANE (0.51) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| Hydrochloric Acid SCHEMBL19834657 | 0.98 | ELANE (0.51) | ELANEATML3MBTL1SLC1A3ALDH1A1 | |
| Malonic Acid SCHEMBL9222807 | 0.91 | ELANE (0.46) | ELANEATML3MBTL1SLC1A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119410679-A | Method for optimizing antibody expression | AMBRX公司 | 2025-02-11 | — | — | CN | claimed |
| CN-114380797-A | Synthesis method of dabigatran etexilate | 山东诚汇双达药业有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-110959041-A | Methods and compositions for enhancing the production of proteins containing unnatural amino acids | AMBRX公司 | 2020-04-03 | — | — | CN | claimed |
| CN-109844108-A | Phosphorylation by regulating and controlling seryl-TRNA synzyme (SERRS) controls angiogenesis | 斯克利普斯研究所 | 2019-06-04 | — | — | CN | claimed |
| US-9909135-B2 | Transgenic plants having altered DAHP synthase activity | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-03-06 | — | — | US | claimed |
| CN-106188080-A | A kind of D phenylalanine ring substituent norcantharidin derivative and preparation method and application | 绍兴文理学院 | 2016-12-07 | — | — | CN | claimed |
| CN-106083873-A | A kind of L phenylalanine ring substituent norcantharidin derivative and preparation method and application | 绍兴文理学院 | 2016-11-09 | — | — | CN | claimed |
| WO-2016133917-A1 | RAAV VECTOR COMPOSITIONS, METHODS FOR TARGETING VASCULAR ENDOTHELIAL CELLS AND USE IN TREATMENT OF TYPE I DIABETES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2016-08-25 | — | — | WO | claimed |
| US-20150044734-A1 | METABOLIC ENGINEERING OF THE SHIKIMATE PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFONIA (US) | 2015-02-12 | — | — | US | claimed |
| EP-2702150-A1 | LIPASE VARIANTS HAVING INCREASED ENZYME SPECIFICITY OR ENHANCED TRANS-SELECTIVITY, AND METHODS OF USE | Frito-Lay Trading Company GmbH (CH) | 2014-03-05 | — | — | EP | claimed |
| WO-2012146935-A1 | LIPASE VARIANTS HAVING INCREASED ENZYME SPECIFICITY OR ENHANCED TRANS-SELECTIVITY, AND METHODS OF USE | FRITO-LAY TRADING COMPANY, GMBH (CH) | 2012-11-01 | — | — | WO | claimed |
| WO-2009029935-A1 | DRUG DELIVERY VEHICLE THAT MIMICS VIRAL PROPERTIES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-03-05 | — | — | WO | claimed |
| US-20080241895-A1 | N-Acetyl-(R,S)-beta-Amino Acid Acylase Gene | AJINOMOTO CO., INC. (JP) | 2008-10-02 | — | — | US | claimed |
| US-5710296-A | ESTERIFICATION, EXPOSURE OF ACTIVE INTERMEDIATE TO PHENOL TO FORM PHENYL ESTER | THE CLOROX COMPANY (US) | 1998-01-20 | — | — | US | claimed |
| EP-0109142-B1 | PEPTIDE AND PSEUDOPEPTIDE DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-09-28 | — | — | EP | claimed |
| US-4474767-A | Peptide and pseudopeptide derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-10-02 | — | — | US | claimed |
| EP-0109142-A2 | Peptide and pseudopeptide derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-05-23 | — | — | EP | claimed |
| CN-115677718-B | Methyl methylamine derivative preparation, pharmaceutical composition and application thereof | 武汉思瓴生物科技有限公司 | 2024-11-01 | — | — | CN | disclosed |
| US-4371612-A | Immobilization of biological material with an acrylonitrile polymer | TOYO JOZO COMPANY, LTD. (JP) | 1983-02-01 | — | — | US | disclosed |
| US-4336334-A | FROM CULTURES OF METHYLOBACTERIUM | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241895-A1 | N-Acetyl-(R,S)-beta-Amino Acid Acylase Gene | ACSL4, FASN, BLVRB | ELANE 1330/4885ATM 2726/4885L3MBTL1 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.